Skip to main content
TipRanks
Go Ultimate75% OFF

Trevor Allred Profile - Oppenheimer Analyst

186 Followers

Trevor Allred's Stock Coverage

PVLA
Palvella Therapeutics
Nov 06, 2026BUYReiterated$232.0010Ratings100%+58.51%
DNTH
Dianthus Therapeutics
May 11, 2026HOLDAssigned―7Ratings100%+106.40%
BBIO
BridgeBio Pharma
May 11, 2026HOLDAssigned―10Ratings75%+18.22%
INVA
Innoviva
Feb 26, 2026BUYDowngraded$35.003Ratings50%-6.35%
MBX
MBX Biosciences, Inc.
Nov 07, 2025BUYReiterated$80.004Ratings100%+305.43%
LGND
Ligand Pharma
Nov 07, 2025BUYReiterated$275.009Ratings100%+76.42%

Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed. See how TipRanks ranks experts and calculates performance.

Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Trevor Allred activity FAQ

What is the performance of Trevor Allred's recommendations?
The percentage of profitable recommendations made by Trevor Allred is 90.32%, and the average return per transaction is 84.10%.
What stocks does Trevor Allred cover?
Trevor Allred mostly covers Palvella Therapeutics, BridgeBio Pharma, Dianthus Therapeutics stocks.
What was Trevor Allred's most profitable rating?
Trevor Allred’s most profitable rating was a buy on MBX Biosciences, Inc. stock on Aug 08, 2025. The return on the trade was 457.70%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here